Resume

Executive R&D leadership in medical devices, imaging, clinical translation, and product development.

Professional Summary

Vice President of Research & Development and Biomedical Engineering Ph.D. with 25+ years of experience leading multidisciplinary teams to develop and clinically validate medical diagnostic devices. Progressed from deep technical expertise in biomedical imaging, algorithms, and instrumentation to executive R&D leadership. Advanced technologies from early-stage research through TRL 5 development, including multi-site clinical trials and system-level architecture redesigns that reduced manufacturing costs by 33% and device footprint by 5x.

Technical & Leadership Expertise

Leadership: R&D organization leadership, Multidisciplinary product development, Technical strategy, Team development, Clinical translation, Design verification and validation

Imaging & Biomedical Systems: Thermoacoustic imaging, Photoacoustic imaging, Ultrasound imaging, Biomedical sensors, Signal processing, Medical imaging, Clinical validation

Software & Modeling: Python, MATLAB, C++, CUDA, k-Wave, Field II, COMSOL, Ansys HFSS, ZEMAX

Hardware & Instrumentation: RF and acoustic systems, Optical and fiber-optic systems, Prototype development, Testing and calibration, Data acquisition (DAQ)

Experience

  • 2024 - Present

    Ann Arbor, MI

    Senior Director of Research and Development / Vice President for Research and Development
    ENDRA Life Sciences Inc.
    Promoted to VP R&D following successful execution of the company’s clinical strategy; restructured the R&D organization and redirected development priorities, contributing to $5M in subsequent fundraising.
    • Led an 8-month engineering effort to identify and resolve the causes of clinical performance failure in the company’s thermoacoustic diagnostic device, taking the system from TRL 0 to TRL 5. Used k-Wave, Ansys HFSS, and internally developed tools to model the acoustic system and identify signal aliasing caused by rib interference, with interference signals hundreds of times larger than the clinical targets.
    • Redesigned the hardware by optimizing RF antenna spacing relative to the acoustic sensor, resolving the interference without requiring a full system redesign.
    • Improved device clinical efficacy, measured by correlation with MRI-PDFF, from 4% to 89%. Directed multi-site clinical trials involving 70+ patients and supported peer-reviewed publications.
    • Led an interdisciplinary team to design a third-generation combined ultrasound and thermoacoustic device to address usability issues. The design reduced projected manufacturing costs by 33%, the probe footprint by half, and the overall system footprint by 5x.
  • 2021 - 2024

    Ann Arbor, MI

    Applied Science Team Leader
    ENDRA Life Sciences Inc.
    Assumed technical ownership for the first- and second-generation device pipeline and independently analyzed clinical data that identified major discrepancies in baseline efficacy, including a 4% correlation with gold-standard measurements.
    • Presented the clinical and technical findings directly to the Board, resulting in a 50% reduction in operating costs and a change in the company’s technical direction.
    • Led the redesign of the acoustic sensor, increasing baseline sensitivity by 6 dB and reducing array-wide sensitivity variation 3-fold.
    • Managed system specifications, QA procedures, and clinical deployment training, while coordinating technical work between company leadership and external engineering contractors.
    • Major contributor to clinical trial design and execution, medical-device validation, ISO 13485, and design verification and validation.
  • 2020 - 2021

    Sunnyvale, CA

    Principal Researcher
    Vortex Medical Imaging
    First US employee hire of an early-stage computational ultrasound startup. Joined a computer-science-focused team as the primary ultrasound imaging expert. Established the company’s US acoustic laboratory, including equipment procurement, custom 3D-printed components, and core testing infrastructure.
    • Defined the technical specifications and characterization methods for a 3D ultrasound probe based on Full Matrix Capture and real-time full waveform inversion for imaging tissue density and speed of sound.
    • Worked with external vendors to transition the probe from design to physical prototype, including defining QA requirements and performance targets for the software and computer science team.
  • 2016 - 2021

    Palo Alto, CA

    Team Leader & Postdoctoral Fellow
    Stanford University School of Medicine, Department of Radiology
    Managed a $1M development budget and a multidisciplinary team of 10–20 engineers, computer scientists, biologists, and clinical researchers. Led development of optical and acoustic technologies from laboratory prototypes toward clinical applications.
    • Led development of a combined photoacoustic and ultrasound prostate imaging system from initial design through prototype development and clinical testing. Authored initial designs and managed external subcontractors responsible for custom ultrasound arrays, multi-port optical waveguides, and specialized cart housings.
    • Implemented real-time signal-processing algorithms and software workflows using MATLAB, Python, and CUDA, increasing photoacoustic imaging data-processing speed by 10x.
    • Designed and executed a validation program covering preclinical testing, ex vivo studies, and a first-in-human feasibility clinical trial for early cancer detection. The project was selected as one of five Stanford projects to receive funding from Philips Healthcare based on its potential for clinical and commercial translation.
  • 2011 - 2016

    Tel Aviv, Israel

    Graduate Researcher – Ph.D. in Biomedical Engineering
    Tel Aviv University, School of Engineering
    Developed novel photoacoustic methods and prototype devices for early detection of osteoporosis, advancing technologies from bench-top concepts to first-in-human clinical studies.
    • Designed experimental systems and studies spanning acoustic instrumentation, biophotonics, statistical optics, and laser-tissue interactions.
  • 2010 - 2011

    Tel Aviv, Israel

    Algorithms Engineer
    OptiCul Diagnostics Ltd.
    Established advanced signal-processing methods and an SVM classifier for a rapid optical bacteria-detection device, evaluating performance against clinical-trial data.
    • Performed and analyzed clinical trials. Used the results to bridge the gap to commercialization, contributing to the company’s early business plan.
  • 2008 - 2010

    Tel Aviv, Israel

    Graduate Researcher – M.Sc., Biomedical Engineering & Management Track
    Tel Aviv University, School of Engineering
    Developed a novel magneto-motive ultrasound method for early detection of cancer, from concept through modeling and benchtop prototype.
  • 2007 - 2008

    Rehovot, Israel

    Algorithms & Image Processing Engineer
    Weizmann Institute of Science
    Designed and implemented a real-time multi-threaded video and sensor analysis system capable of capturing and processing rapidly changing, unpredictable whisker movement to control a live feedback loop.
  • 2000 - 2004

    Israel

    Operations Research Officer
    Israel Defense Forces
    Applied quantitative analysis and operational modeling to support planning and decision-making. Selected for the Lotem academic and technical military program.

Education

Awards & Honors

  • SPARK Program Fellow
    Stanford University

    Selected as one of 14 Stanford teams for industry translation of a photoacoustic marker for imaging bacterial infections.

  • Philips Healthcare Fellow
    Stanford University Department of Radiology

    Awarded for development of a dual ultrasound/photoacoustic imaging system.

  • Sir Peter Michael Foundation Fellow
    Sir Peter Michael Foundation

    Selected as a national researcher for excellence in clinical translation of prostate cancer photoacoustic imaging at Stanford University.

  • Sir Charles Clore Scholar
    Clore Foundation

    Selected as one of nine scholars nationwide.